14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AZN.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for AstraZeneca PLC stock after losing 0.87%
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 10, 2024 Gain 12.28% PDF

The AstraZeneca PLC stock price fell by -0.87% on the last day (Friday, 3rd May 2024) from £12,156.00 to £12,050.00. During the last trading day the stock fluctuated 1.40% from a day low at £12,010.00 to a day high of £12,178.00. The price has risen in 7 of the last 10 days and is up by 10.09% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -327 thousand shares and in total, 2 million shares were bought and sold for approximately £19.70 billion.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at £12,231.16 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 18.34% during the next 3 months and, with a 90% probability hold a price between £13,114.06 and £14,474.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AZN.L Signals & Forecast

The AstraZeneca PLC stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately £12,068.00. On a fall, the stock will find some support from the long-term average at approximately £10,976.69. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -0.99%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for AstraZeneca PLC stock

On the downside, the stock finds support just below today's level from accumulated volume at £10,450.00 and £10,036.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AstraZeneca PLC finds support just below today's level at £10,450.00. If this is broken, then the next support from accumulated volume will be at £10,036.00 and £9,724.00.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved £168.00 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 2.20%.

The AstraZeneca PLC stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: £11,599.94 (-3.73%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 81 and this increases the risk substantially. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (AZN.L) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect AstraZeneca PLC to open at £12,079.33, and during the day (based on 14 day Average True Range), to move between £11,810.03 and £12,289.97, which gives a possible trading interval of +/-£239.97 (+/-1.99%) up or down from last closing price. If AstraZeneca PLC takes out the full calculated possible swing range there will be an estimated 3.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at £12,062.00 (0.10%) than the support at £10,450.00 (13.28%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AstraZeneca PLC stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AstraZeneca PLC stock to perform well in the short-term.

Current score: 2.677 Buy Candidate Unchanged

Predicted Opening Price for AstraZeneca PLC of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
£12,079.33 ( 0.243%) £12,050.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AZN.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12,247.33 1.64 %
R2 12,183.16 1.11 %
R1 12,143.51 0.776 %
Current price: 12,050.00
Support S1 12,015.16 -0.289 %
S2 11,975.51 -0.618 %
S3 11,911.33 -1.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12,170.00 1.00 %
R2 12,156.00 0.88 %
R1 12,062.00 0.0996 %
Current price 12,050.00
Support S1 10,450.00 -13.28%
S2 10,036.00 -16.71%
S3 9,724.00 -19.30%

AZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 22, 2024 Feb 22, 2024 Mar 25, 2024 £156.00 1.50%
2 Feb 09, 2023 Feb 23, 2023 Mar 27, 2023 £162.80 1.45%
3 Jul 29, 2022 Aug 11, 2022 Sep 12, 2022 £76.40 0.719%
4 Feb 10, 2022 Feb 24, 2022 Mar 28, 2022 £145.30 1.47%
5 Jul 29, 2021 Aug 12, 2021 Sep 13, 2021 £64.80 0.80%

FAQ

What is the symbol for AstraZeneca PLC Stock and on which exchange is it traded?
The symbol for AstraZeneca PLC is AZN.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell AstraZeneca PLC Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AstraZeneca PLC stock to perform well in the short-term.

How to buy AstraZeneca PLC Stock?
AstraZeneca PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AstraZeneca PLC Stock.

What's the current price of AstraZeneca PLC Stock?
As of the end of day on the May 03, 2024, the price of an AstraZeneca PLC (AZN.L) share was £12,050.00.

What is the 52-week high and low for AstraZeneca PLC Stock?
The 52-week high for AstraZeneca PLC Stock is £12,488.00 and the 52-week low is £9,463.00.

What is the market capitalization of AstraZeneca PLC Stock?
As of the May 03, 2024, the market capitalization of AstraZeneca PLC is 186.804B.

When is the next earnings date for AstraZeneca PLC?
The upcoming earnings date for AstraZeneca PLC is May 31, 2024.
Click to get the best stock tips daily for free!

About AstraZeneca PLC

AstraZeneca PLC AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/... AZN.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT